The effect of Mangosteen on Inflammation, Oxidative Status, and Hepatorenal Function in Patients with Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.32947/ajps.v26i2.1379Keywords:
Mangosteen, Type2 diabetes mellitus, Superoxide dismutase-1, Oxidative status, InflammationAbstract
Background: Oxidative stress (OS) and inflammation are significant factors in the etiology of type 2 diabetes mellitus (T2DM). Mangosteen (MG) possesses anti-inflammatory and antioxidant activities due to its high concentrations of xanthones, particularly (α-MG) and (γ-MG).
Objectives: This study aims to evaluate MG effect as an adjuvant therapy on inflammation, antioxidant activity, hepatic, and renal function among newly diagnosed T2DM patients.
Methods: This is a prospective randomized-controlled open-label study carried out over 12-week period at the National Diabetes Center for Treatment and Research. Group 1: included patients treated with sitagliptin/metformin tab. (50/1000 mg) twice daily in addition to non-pharmacological therapy (lifestyle modification), Group 2: included patients treated with sitagliptin/metformin tab. (50/1000 mg) twice daily plus MG cap. (500mg) two times daily in addition to non-pharmacological therapy (lifestyle modification). Fasting blood glucose (FBG), HbA1c, fasting serum insulin (FSI), HOMA-IR, Serum interlukin-6 (IL-6), superoxide dismutase-1 (SOD-1), liver and kidney parameters were assessed at baseline and at the end of the study.
Results: The total number of participants was 47 patients; Group 1 included 22 patients and Group 2 included 25 patients. After 12 weeks, IL-6 decreased significantly in both groups (p<0.05) and SOD-1 showed significant improvement in patients receiving MG (p<0.05). Liver and renal parameters remained within normal limits in both groups.
Conclusion: Mangosteen (MG) supplementation was safe and well tolerated and may have a potential antioxidant benefit, with no additive effect on inflammation. However, further studies are required to confirm these findings.
References
1- Dawood MH, Abdulridha MK, Qasim HS. Impact of Pyridoxine Supplement on Oxidative Stress in Type 2 Diabetic Patients. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2024;24(1):89-104.
2- Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107-11.
3- Jawad AN, Kadhim KA, Alzajaji QB, Al-Neshmi H. Assessment of Factors Affecting Therapeutic Response of the DPP-4 Inhibitor Sitagliptin in A Sample of Iraqi Type 2 Diabetic Patients. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2024;24(3):311-9.
4- Ye J, Wu Y, Yang S, Zhu D, Chen F, Chen J, et al. The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019. Frontiers in endocrinology. 2023;14:1192629.
5- Tang S-S, Zhao X-F, An X-D, Sun W-J, Kang X-M, Sun Y-T, et al. Classification and identification of risk factors for type 2 diabetes. World Journal of Diabetes. 2025;16.
6- Hanrahan JE, Subroto PAM, Priawan RP, Krisnamurti DGB. Potential holistic preventive and therapeutic effects of garcinia mangostana extract or isolates in type 2 diabetes mellitus: A review. Int J Appl Pharm. 2019;11:7-11.
7- Lima JE, Moreira NC, Sakamoto-Hojo ET. Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2022;874:503437.
8- Omoruyi F, Sparks J, Stennett D, Dilworth L. Chapter 40 - Superoxide dismutase as a measure of antioxidant status and its application to diabetes. In: Preedy VR, editor. Diabetes (Second Edition): Academic Press; 2020. p. 409-17.
9- Sater MS, AlDehaini DMB, Malalla ZHA, Ali ME, Giha HA. Plasma IL-6, TREM1, uPAR, and IL6/IL8 biomarkers increment further witnessing the chronic inflammation in type 2 diabetes. Hormone Molecular Biology and Clinical Investigation. 2023;44(3):259-69.
10- Sun C, Liu Y, Zhan L, Rayat GR, Xiao J, Jiang H, et al. Anti-diabetic effects of natural antioxidants from fruits. Trends in Food Science & Technology. 2021;117:3-14.
11- Lee J, Noh S, Lim S, Kim B. Plant extracts for type 2 diabetes: From traditional medicine to modern drug discovery. Antioxidants. 2021;10(1):81.
12- Blahova J, Martiniakova M, Babikova M, Kovacova V, Mondockova V, Omelka R. Pharmaceutical drugs and natural therapeutic products for the treatment of type 2 diabetes mellitus. Pharmaceuticals. 2021;14(8):806.
13- Zonouz AM, Rahbardar MG, Hosseinzadeh H. Antidotal and protective effects of mangosteen (Garcinia mangostana) against natural and chemical toxicities: A review. Iranian Journal of Basic Medical Sciences. 2023;26(5):492.
14- Saraswathy S, Lalitha L, Rahim S, Gopinath C, Haleema S, SarojiniAmma S. A review on synthetic and pharmacological potential of compounds isolated from Garcinia mangostana Linn. Phytomed Plus. 2022; 2 (2): 100253. 2022.
15- binti Zamarudin Z, bin Abdullah Sani MS, Nordin NFH, Amid A, Hashim AM. Mangosteen (Garcinia mangostana): Extraction, purification, bioactivities and toxicities. Halalsphere. 2023;3(2):13-27.
16- Mahmudah Ra, Adnyana IK, Sukandar EY. Molecular docking studies of α-mangostin, γ-mangostin, and xanthone on peroxisome proliferator-activated receptor gamma diphenyl peptidase-4 enzyme, and aldose reductase enzyme as an antidiabetic drug candidate. Journal of advanced pharmaceutical technology & research. 2021;12(2):196-208.
17- Setiawan AA, Budiman J, Prasetyo A. Anti-inflammatory potency of mangosteen (Garcinia mangostana L.): a systematic review. Open Access Macedonian Journal of Medical Sciences. 2023;11(F):58-66.
18- Prayitno A, Oetari R, Shahiddin I, Elmanda AY, Septiarini AD, Dharmayanti L, et al. α-Mangosteen from Garcinia Mangostana Linn and its Effect in Blood Insulin and Sugar Levels in Hyperglycemic Rat. Journal of Clinical & Experimental Investigations. 2021;12(2).
19- Elmund B, Hartrianti P. Evaluation of mangosteen (Garcinia mangostana) antioxidant activity in clinical trials and in vivo animal studies: A systematic review. Journal of Applied Pharmaceutical Science. 2020;10(12):114-29.
20- Ovalle-Magallanes B, Eugenio-Pérez D, Pedraza-Chaverri J. Medicinal properties of mangosteen (Garcinia mangostana L.): A comprehensive update. Food and Chemical Toxicology. 2017;109:102-22.
21- Safaei R, Sakhaee K, Saberifar M, Fadaei MS, EdalatJoo S, Fadaei MR, et al. Mechanistic insights into the xanthones present in mangosteen fruit (Garcinia mangostana) and their applications in diabetes and related complications. Journal of Food Biochemistry. 2023;2023(1):5334312.
22- Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):45-63.
23- Promyos N, Phienluphon PP, Wechjakwen N, Lainampetch J, Prangthip P, Kwanbunjan K. Inverse Correlation of Superoxide Dismutase and Catalase with Type 2 Diabetes among Rural Thais. Nutrients. 2023;15(9):2071.
24- Akbari M, Hassan-Zadeh V. IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology. 2018;26(3):685-98.
25- Yaribeygi H, Mirmohammadkhani M, Rashidy-Pour A, Sathyapalan T, Foroutan M, Najmaldin A, et al. Addition of sitagliptin to ongoing metformin improved metabolic profile and pancreatic function via normalizing inflammatory cytokines’ levels in patients with type 2 diabetes, a randomized double-blinded clinical trial. Expert Review of Endocrinology & Metabolism. 2025:1-9.
26- Lin H, Ao H, Guo G, Liu M. The Role and Mechanism of Metformin in Inflammatory Diseases. J Inflamm Res. 2023;16:5545-64.
27- ZI AM, Sargowo D, Rizal A, Tjahjono CT, Widito S, Rahimah AF. The role of Garcinia mangostana pericarp extract as antioxidant to inhibit atherosclerosis process in high risk framingham score patient; original article. Heart Science Journal. 2021;2(1):25-9.
28- Handayani O, Sargowo D, Rohman MS, Satrijo B, Tjahjono CT, Hendrawan D. The effect of add-on Garcinia mangostana L. extract on endothelial dysfunction in type 2 diabetes mellitus subjects with high risk Framingham Score: A cohort study. Heart Science Journal. 2020;1(1):21-5.
29- Udani JK, Singh BB, Barrett ML, Singh VJ. Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study. Nutrition journal. 2009;8(1):48.
30- Widowati W, Darsono L, Suherman J, Fauziah N, Maesaroh M, Erawijantari PP. Anti-inflammatory effect of mangosteen (Garcinia mangostana L.) peel extract and its compounds in LPS-induced RAW264. 7 cells. Natural product sciences. 2016;22(3):147-53.
31- Soetikno V, Andini P, Iskandar M, Matheos CC, Herdiman JA, Kyle IK, et al. Alpha-Mangosteen lessens high-fat/high-glucose diet and low-dose streptozotocin induced-hepatic manifestations in the insulin resistance rat model. Pharmaceutical Biology. 2023;61(1):241-8.
32- Karim N, Jenduang N, Tangpong J. Anti-glycemic and anti-hepatotoxic effects of mangosteen vinegar rind from Garcinia mangostana against HFD/STZ-induced type II diabetes in mice. Polish Journal of Food and Nutrition Sciences. 2018;68(2):163-9.
33- Xie Z, Sintara M, Chang T, Ou B. Daily consumption of a mangosteen‐based drink improves in vivo antioxidant and anti‐inflammatory biomarkers in healthy adults: a randomized, double‐blind, placebo‐controlled clinical trial. Food science & nutrition. 2015;3(4):342-8.
34- Kudiganti V, Kodur RR, Kodur SR, Halemane M, Deep DK. Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects. Lipids in Health and Disease. 2016;15:1-11.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mays Qays Habeeb, Manal Khalid Abdulridha, Duygu ERYAVUZ ONMAZ, Isam Noori Salman
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
